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In Brief
Antigen-presenting dendritic cells
approach and enter lymphatic capillaries
in a chemokine CCL21-dependent
manner. Vaahtomeri et al. show that
migrating dendritic cells trigger
chemokine-mediated feedback via direct
contact with lymphatic endothelia, which
locally release CCL21 and thus promote
transmigration.
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Trafficking cells frequently transmigrate through
epithelial and endothelial monolayers. How mono-
layers cooperate with the penetrating cells to sup-
port their transit is poorly understood. We studied
dendritic cell (DC) entry into lymphatic capillaries as
a model system for transendothelial migration. We
find that the chemokine CCL21, which is the decisive
guidance cue for intravasation,mainly localizes in the
trans-Golgi network and intracellular vesicles of
lymphatic endothelial cells. Upon DC transmigration,
these Golgi deposits disperse and CCL21 becomes
extracellularly enriched at the sites of endothelial
cell-cell junctions.Whenwe reconstitute the transmi-
gration process in vitro, we find that secretion
of CCL21-positive vesicles is triggered by a DC
contact-induced calcium signal, and selective cal-
cium chelation in lymphatic endothelium attenuates
transmigration. Altogether, our data demonstrate a
chemokine-mediated feedback between DCs and
lymphatic endothelium, which facilitates transendo-
thelial migration.
INTRODUCTION
Endothelial and epithelial monolayers and their associated base-
ment membranes form physical and functional barriers sepa-
ratingdistinct tissuecompartments. Thesebarriers are frequently
breached, e.g., by immune cells as part of their homeostatic or in-
flammatory trafficking, by tumor cells during metastatic spread,
or during tissue reorganizations in development. Although such
transmigration events do not follow one stereotypic pattern,
certainmechanisms recur. First, often themigrating cell is guided
toward thebarrier by extracellular guidancecues suchaschemo-
kines. Second, adhesion of the migrating cell to the barrier is
mediated by sequential cell-cell interactions, as exemplified in
the leukocyte extravasation cascade (Reymond et al., 2013;
Vestweber, 2015). Third, transmigration across thebarrier usually902 Cell Reports 19, 902–909, May 2, 2017 ª 2017 The Author(s).
This is an open access article under the CC BY-NC-ND license (http://occurs via entry portals, which may either be developmentally
regulated (Nourshargh et al., 2010; Seifert and Lehmann, 2012)
or induced by the migrating cell itself (Nourshargh et al., 2010;
Vestweber, 2015).
Despite their apico-basal asymmetry, endothelia, and epithelia
are often penetrated in both directions: e.g., neutrophils usually
extravasate blood vessels from luminal to interstitial but can
also transmigrate in the reversed direction (intravasation) (Wood-
fin et al., 2011). Likewise, tumor cells intravasate blood vessels
upon leaving the primary tumor and extravasate to colonize
distant organs (Reymond et al., 2013). Hence, rather than acting
as pre-patterned gradients, which stereotypically guide the cells
across the barrier, the directional cues governing transmigration
might act locally and dynamically.
Lymphatic endothelial cells (LECs) of the lymphatic capillaries
form a barrier for intravasating leukocytes and tumor cells. Den-
dritic cells (DCs) enter these vessels on their way from the pe-
riphery to the lymph nodes, where DCs activate lymphocytes
as part of the adaptive immune response (Fo¨rster et al., 2008).
DCs are guided from the interstitium toward the lymphatic
capillaries by gradients of the chemokine CCL21 (Weber et al.,
2013), which is homeostatically secreted by the LECs (Nakano
and Gunn, 2001). After arrival at the lymphatic capillary, DCs
penetrate the basement membrane (Pflicke and Sixt, 2009)
and the LEC junctions (Baluk et al., 2007). The molecular mech-
anisms directing DCs into the vascular lumen, which we investi-
gate here, are largely unclear.RESULTS AND DISCUSSION
CCL21 Is Mobilized upon Interactions between
Dendritic Cells and Lymphatic Endothelia
DCs are attracted to the vicinity of lymphatic capillaries via gra-
dients of CCL21 (Weber et al., 2013). Notably, CCL21 immunos-
tainings in non-permeabilized tissues show a very faint intersti-
tial signal compared to a strong signal localizing to LECs in
permeabilized tissues (Johnson and Jackson, 2010; Tal et al.,
2011; Weber et al., 2013). These depots are observed as peri-
nuclear puncta (Johnson and Jackson, 2010; Weber et al.,
2013), which co-stain for the Golgi marker GOLPH4 (Figure 1A)creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Dendritic Cell Entry into Mouse
Dermal Lymphatic Capillaries InducesMobi-
lization of CCL21
(A) Mouse dermal lymphatic capillary stained for
LYVE1 (green), GOLPH4 (red), CCL21 (white), and
nuclei (DAPI, blue). Yellow arrows indicate co-
localization of CCL21 and Golph4. Zoom-in of
boxed area is shown below.
(B) TAMRA-labeled DCs (red) and LYVE1-stained
lymphatic capillaries (green) after 3 hr 300 invasion.
Yellow lines indicate the plane of orthogonal sec-
tion, and yellow arrow highlights a transmigration
event.
(C) LYVE1 (green), CCL21 (white), and nuclei (DAPI,
blue) of the ear dermis after 3 hr 300 in presence or
absence (control) of TAMRA-labeled DCs (red).
Bottom image shows zoom-in of boxed area.
White arrows indicate dispersion of CCL21 (yellow
arrow in control).
(D) Dot blot graph shows ratio of signal in high
intensity CCL21 depots to CCL21 in other areas of
LECs. Columns represent mean values ± SD of
control (n = 3) and + DC (n = 5) samples of300 mm
long lymphatic vessel stretches.
(E) Transmission electron micrograph of CCL21
staining of dermis. Black arrows indicate over-
lapping LEC tips at cell-cell junctions, yellow arrow
detachment of LECs from interstitial extracellular
matrix, white arrow rearrangement of collagen
bundles, and blue arrow a silver-amplified CCL21
Immunogold label.
(F) Quantification of extracellular CCL21 staining at
sites of DC-associated tissue alterations (see E)
compared to intact area in same sample or sample
devoid of DCs. Bar graph shows mean ± SD of two
(–DC) and four (+DC) independent ear samples.
Scale bars, 10 mm (A); 50 mm (B and C); 10 mm in
zoom-in images; and 500 nm (E).
See also Figure S1.and disperse upon Golgi-endoplasmic reticulum (ER) disrupting
Brefeldin A treatment (Weber et al., 2013). In addition to these
trans-Golgi depots, CCL21 locates to intracellular vesicles
(Figures 1A and S1A) (Johnson and Jackson, 2010), which
might represent chemokine en route to homeostatic secretion
or stores for ‘‘on demand’’ release. To test if intravasation of
DCs changes CCL21 distribution, we layered in vitro-generated
DCs on mouse ear explants. In this setup, DCs enter the tissue
within minutes and migrate along gradients of interstitial CCL21
to ultimately intravasate into the dermal lymphatic vessels
(Pflicke and Sixt, 2009; Weber et al., 2013; Weber and Sixt,
2013) (Figure 1B). In lymphatic capillaries, which had been
entered by many DCs, we found that perinuclear CCL21 depots
were dispersed and overall diminished (Figures 1C and 1D).This change in CCL21 distribution was
not observed at sites where few DCs in-
travasated or in ears loaded with DCs
deficient for the CCL21 receptor CCR7
(Figure S1B). Ccr7/ DCs cannot read
the interstitial CCL21 gradient and there-
fore do not interact with the lymphaticcapillaries (Fo¨rster et al., 1999; Ohl et al., 2004; Weber et al.,
2013).
To study whether mobilization of CCL21 upon DC intravasa-
tion was associated with extracellular CCL21 enrichment, we
employed immunometal transmission electron microscopy. In
line with the immunofluorescence analysis (Figure 1A), intracel-
lular CCL21 was found enriched in the nuclear periphery (Fig-
ure S1C) and, more sparsely, in intracellular vesicles of control
samples (Figure S1D). Extracellular CCL21 was mostly detected
within 1 mm distance of the basolateral side of LECs with no ev-
idence of CCL21 gradients extending from the basolateral to the
luminal side of the LECs (Figure 1E). In samples exposed to DCs,
local presence of DCs was associated with poorly organized
interstitial collagen and partial detachment of the LECs fromCell Reports 19, 902–909, May 2, 2017 903
Figure 2. CCL21-Positive Vesicles Localize
to Golgi-Secretory Pathway and Traffic
along Microtubules
(A) Giantin (white) and nuclear staining (DAPI, blue)
of CCL21-mCherry (red), CCL21DN-mCherry, or
CCL21DC-mCherry expressing LECs. Insets show
Golgi localized mCherry signal (yellow arrows) with
or without staining of Golgi marker giantin.
(B) Quantification of mCherry intensities in super-
natants of CCL21-mCherry, CCL21DN-mCherry,
and CCL21DC-mCherry expressing LECs. Dot blot
graph shows a mean ± SD of pooled data from two
independent experiments, n = 4 for each construct.
Intensities are normalized to media background,
which is set as 1.
(C) Basolateral non-directed tracks of TIRF-imaged
CCL21-mCherry-positive vesicles are indicated
with white, directed tracks heading toward Golgi
area with green, directed tracks toward cell pe-
riphery with red, the Golgi apparatus with a dashed
yellow line, and the boundaries of cell contact
surface with dashed white line. Yellow arrow in-
dicates a white trajectory representing random
movement within a confined area.
(D) TIRF imaging of CCL21DC-mCherry (red) and
EGFP-tubulin-a (green) expressing primary LEC.
White arrow highlights one CCL21DC-mCherry
positive vesicle (red) throughout the image series.
SeeMovie S1. Scale bars, 10 mm (A); 2 mm (CandD).
See also Figure S2.the interstitium (Figures 1E, S1E, and S1F). Importantly, these
signatures of DC intravasation were associated with extracel-
lular accumulations of basolateral, but not luminal, CCL21
(Figure 1E-1F). These accumulations were most prominent at
LEC-LEC junctions of detached endothelia (Figure 1E), whereas
sheer proximity of DCs seemed insufficient to discharge chemo-
kine (Figure S1G). Based on these findings, we hypothesize that
contact between DCs and LECs triggers acute CCL21 secretion.
Triggered exocytosis of chemokine is reminiscent of exocytotic
targeting of the adhesion molecule PECAM to areas of lympho-
cyte transmigration at the blood endothelium (Mamdouh et al.,
2003). It might provide local guidance or act as a landmark for
following DCs, which have been shown to intravasate with
increased efficiency (MartIn-Fontecha et al., 2003).
CCL21 Leaves the Golgi Apparatus via Microtubules
To directly study CCL21 secretion, we established a trace-
able in vitro setup, where we lentivirally expressed variants of
CCL21 in human dermal LECs, which recapitulated localization
to the Golgi secretory pathway (compare Figures 2A and S1A)
(de Jong et al., 2005, 2008). Secretion of CCL21 into the cell cul-904 Cell Reports 19, 902–909, May 2, 2017ture supernatant was dependent on the
N-terminal signaling peptide (Figures 2A
and 2B). Surprisingly, exclusion of the
CCL21DN-mCherry from the secretory
pathway led to nuclear localization,
possibly owing to a potential bipartite nu-
clear localizing signal in mature CCL21
(aa 21–50). The loss of the heavily cationicC terminus (CCL21DC) did not affect localization to the Golgi
secretory pathway (Figure 2A) but instead prevented binding of
CCL21 to the cell culture dish surface (Figure S2A) and lead to
increased CCL21 in the cell culture supernatant (Figure 2B).
This was in line with previous findings, showing that the C termi-
nus immobilizes CCL21 to charged surfaces and glycosamino-
glycans (Hirose et al., 2002).
To trace the intracellular trafficking routes of CCL21,
we performed real-time total internal reflection fluorescence
(TIRF) microscopy. Tracking of CCL21-mCherry-positive vesi-
cles showed two modes of behavior: some vesicles rapidly
advanced along linear trajectories, whereas others moved
randomly within confined areas (Figure 2C). Linear tracks con-
nected Golgi area and the LEC periphery (Figure 2C), matching
the distribution pattern of microtubules (Figure S2B). Accord-
ingly, CCL21 was microtubule-associated as revealed by im-
munostaining of untagged CCL21 and CCL21DC (Figure S2B)
and live imaging of CCL21DC-mCherry (Figure 2D; Movie S1).
Microtubule disruption by nocodazole abolished the compo-
nent of directed movement (Movie S1) confirming that CCL21
is transported along microtubules, which is analogous to the
Figure 3. Regulation of CCL21 Secretion
(A) TIRF microscopy of CCL21-mCherry vesicles
(white) of a single LEC after addition of 5 mM ion-
omycin. Yellow arrows indicate vesicles at time
point 000, secretion events are highlighted by white
arrows. Scale bar, 2 mm. See Movie S2.
(B) Quantification of mCherry intensities of
CCL21DC-mCherry expressing LEC culture su-
pernatant subsequent to 60 control or 5 mM ion-
omycin treatment. Bar graph shows mean ± SD of
pooled samples from 3 independent experiments,
n = 5 (control) and 6 (ionomycin).
(C) Quantification of mCherry intensities of culture
supernatants of CCL21DC-mCherry expressing
LECs 4 hr after washout of 1 hr long control or
10 mM BAPTA-AM treatment. BAPTA-AM is a cell-
permeant Ca chelator, which is trapped in cells
and binds intracellular calcium via carboxylic acid
functional groups thus severely decreasing intra-
cellular-free calcium. Bar graph shows mean ± SD
of pooled samples from three independent exper-
iments, n = 7 for each condition. Intensities of
(B) and (C) are normalized to media background,
which is set as 1.
(D) Quantification of pooled data from all TIRF
experiments on single vesicle secretion. Data
points show secretion frequency in control, 5 mM
ionomycin-, or 500 ng/mL latrunculin B-treated
CCL21-mCherry or CCL21DC-mCherry express-
ing single LECs as indicated in the figure. The dot
blot graph shows mean ± SD secretion frequency
in pooled data of single cells from 6 independent
experiments, cell number (n) is indicated in the
figure.
(E) Data points show CCL21-mCherry vesicle
speed, displacement, and duration in the TIRF
imaging plane (basolateral membrane) in control and 13 latrunculin B (500 ng/mL)-treated single LECs, which displayed highest CCL21 secretion (see Figure 3D
latrunculin B column). The dot blot graph showsmean ± SD of vesicle tracks (51–513/cell) in pooled data of single cells (n = 12 for control and 13 for latrunculin B)
of three independent experiments. See Movie S3.transport of insulin in secretory pancreatic beta-cells (Boyd
et al., 1982; Varadi et al., 2003). Similarly to insulin, some of
the linear trajectories of CCL21 vesicles were directed toward
the cell periphery and some toward the Golgi area, suggesting
regulation of vesicle dwell time at the LEC periphery (Zhu et al.,
2015).
CCL21 Secretion Is Regulated by Calcium and Cortical
Actin
TIRF imaging revealed that occasionally CCL21-mCherry vesi-
cles were discharged into the extracellular space. Regulated
discharge of plasma membrane-docked vesicles is often
initiated by calcium (Ca) binding to synaptotagmins, which
triggers the actual membrane fusion event (S€udhof, 2012).
Accordingly, the Ca ionophore ionomycin triggered robust
CCL21-mCherry and CCL21DC-mCherry secretion as directly
observed with TIRF microscopy as a sudden and transient in-
crease in CCL21 intensity (Figures 3A and 3D; Movie S2).
Such flashes are due to the exponential increase in TIRF signal
once the quantum of fluorescent probe enters the glass-water
interface below the cell (Axelrod, 1981), which is then followed
by rapid dilution of the radially diffusing probe. Bulk mCherry
signal in the LEC culture supernatant was increased by ionomy-cin (Figure 3B). Further, basal secretion seemed at least
partially dependent on Ca as chelation of intraendothelial Ca
with BAPTA-AM causing a 30% reduction in CCL21DC-
mCherry secretion (Figure 3C).
Ionomycin did not trigger secretion of all plasma membrane-
associated vesicles (Movie S2). Some of these vesicles might
not be plasma membrane-docked, but rather sequestered
within the cortical actin meshwork, which has to be pene-
trated before the vesicles can directly contact the membrane
(Nakata and Hirokawa, 1992; Oheim and St€uhmer, 2000; Giner
et al., 2007). When we visualized the cortical actin mesh-
work of LECs with Lifeact-EGFP, lateral movements similar
to that of CCL21-mCherry vesicles were apparent (Movie
S3). Actin disassembly by latrunculin B substantially increased
the frequency of secretion events (Figure 3D; Movie S3),
likely because of enhanced contact between vesicles and
secretory machinery. Accordingly, the LECs displaying latrun-
culin B-induced secretion showed increased movement of
vesicles in the basolateral plane as well as in z-direction (re-
vealed by disappearance of vesicles from the TIRF field) (Fig-
ure 3E; Movie S3). These results suggest that the cortical actin
meshwork controls CCL21 secretion by restricting membrane-
docking of vesicles.Cell Reports 19, 902–909, May 2, 2017 905
Figure 4. Endothelial Ca Signaling Facili-
tates DC Transmigration In Vitro
(A) Transmission electron micrograph at a site of
DC-LEC interaction at ear dermis lymphatic capil-
lary. Black line indicates thinning of endothelial cell
at site of interaction. Interstitium (I), lumen (L), LEC,
and DC are marked.
(B) Immunoelectron micrograph of whole mount
preparation labeled for CCL21 (silver amplified
gold particles) at a site of DC-LEC interaction in ear
dermis. The yellow arrows in (A) and (B) indicate the
endothelial detachment from interstitium.
(C) Phase contrast imaging of an in vitro trans-
migration event from the apical to basolateral side
of the LEC monolayer. White arrow points at lead-
ing edge, yellow arrow at cell body, and blue arrow
at trailing edgeof transmigratingDC.SeeMovieS4.
(D) Epifluorescence imaging of Oregon Green
BAPTA-AM-treated LECs (green) and TAMRA-
labeled DCs (red). Blue arrow indicates DC leading
edge and yellow arrow LEC displaying a transient
Ca peak upon DC contact. Below the image, the
kymograph and the corresponding line graph of
the Oregon green BAPTA-AM intensity in the LEC
(highlighted with yellow arrow) are shown. See
Movie S5.
(E)Quantificationof LECsdisplayingCapeaksupon
addition of fresh media, DCs, DC-conditioned me-
dia, or Mycalolide B-treated DCs. Dot blot graph
showsmean ± SD of pooled samples. Fresh media
and DC samples represent eight independent ex-
periments (n=18and19, respectively), ofwhich two
experiments included Mycalolide B-treated DCs
(n = 6), and three experiments included conditioned
media samples (n = 4). Data are normalized to
average of DCs sample, which is set as 1.
(F)Quantification ofDC transmigration on control or
10mMBAPTA-AM (B-AM)-treatedCCL21-mCherry
or CCL21DC-mCherry expressingmonolayers. Dot
blot graph shows mean ± SD of pooled samples
from three independent experiments, n = 7 for
BAPTA-AM-treated CCL21DC-mCherry express-
ing LECs and eight for all other conditions. Data are
normalized to average of controls, which is set as 1.
See Movie S6.
(G) Schematic of DC-induced Ca influx and CCL21
secretion. Scale bars, 500 nm (A and B); 50 mm (C);
and 10 mm (D).
See also Figure S2.DCs Induce Lymphatic Endothelial Ca Fluxes via Cell-
Cell Contact
The finding that Ca influx triggers CCL21 secretion in LECs (Fig-
ures 3A, 3B, and 3D; Movie S2) together with our in situ finding
that DCs cause release of CCL21 (Figures 1E and 1F) suggested
that DC-LEC interactionsmight induce Ca signals in LECs similar
to Ca signals in blood endothelia when being transmigrated by
polymorphonuclear leukocytes (Huang et al., 1993). While Ca
signaling can be induced in several ways, we were struck by
our in situ observation of DCs probing LECs with a blunt foot-
like processes (Figures 4A and 4B), which were reminiscent of
lymphocyte processes physically penetrating blood endothe-
lium (Carman et al., 2007; Shulman et al., 2011). DC protrusions
considerably deformed LECs and even detached them locally906 Cell Reports 19, 902–909, May 2, 2017from the underlying extracellular matrix (Figures 4A, 4B, S1E,
and S1F). This suggested that DCs exert pushing forces on
LECs, which might promote communication via extended cell-
cell contacts. To investigate whether direct interaction was
required for Ca signals, LECs were grown to confluency, and
DCs were layered on top. In this setting, DCs effectively transmi-
grated the monolayer (Maddaluno et al., 2009) as revealed by
phase contrast live cell imaging (Figure 4C; Movie S4). Trans-
migration was dependent on the secretion of CCL21, as non-
infected or CCL21DN-mCherry-infected LECs were only occa-
sionally penetrated by DCs (Figure S2D; Movie S4). Importantly,
DCs interacting with the apical side of LECs and DCs in transit
through the monolayer induced an increase in Ca concentration
in LECs as revealed by time-lapse imaging of a Ca sensor
(Figure 4D; Movie S5). At the population level, LECs showed a
low basal frequency of Ca transients, which was increased
4.5-fold upon addition of DCs (Figure 4E). Unlike DCs, DC-condi-
tioned media did not induce an increase in Ca concentration
(Figure 4E) excluding a major role for secreted factors. Further,
pre-treatment of DCs with Mycalolide B, an irreversible actin de-
polymerizing agent (Hori et al., 1993; Saito et al., 1994), which
prevents formation of actin-based cell protrusions, did not
abolish Ca transients (Figure 4E). These results suggest that mo-
lecular engagements at the DC-LEC interface are sufficient trig-
gers. Earlier, DC expressed b2 integrins (LFA-1) and its lymphatic
endothelial ligand ICAM have been shown to be necessary
for in vivo and in vitro transmigration of inflamed but not homeo-
static endothelia, where ICAM is not expressed (Johnson et al.,
2006; Johnson and Jackson, 2010; Vigl et al., 2011; Teijeira
et al., 2013). Accordingly, b2 integrins were dispensable for the
DC entry into the dermal lymphatic capillaries as shown before
(Figure S2E) (La¨mmermann et al., 2008). At sites of intravasated
b2 deficient (Itgb2/) DCs, CCL21 depots were dispersed from
Golgi similar to wild-type DC samples (Figures S2E and S2F).
Thus, other molecular interactions at the DC-LEC interface,
such as the plexin1A-semaphorin3A axis (Takamatsu et al.,
2010), L1 (Maddaluno et al., 2009), or yet unidentified factors
might trigger the signal.
DC-Stimulated Lymphatic Endothelial Ca Fluxes
Facilitate Transendothelial Migration
To directly investigate whether lymphatic endothelial Ca
signaling was necessary for the transendothelial migration of
DCs, we selectively chelated endothelial Ca with BAPTA-AM.
We compared the responses to both CCL21-mCherry and
CCL21DC-mCherry, because full-length CCL21-mCherry accu-
mulates on the cell culture dish surface (Figure S2A), which is
not seen in vivo (Figure 1E). Thus, we presumed that the trun-
cated chemokine more faithfully mimics the in vivo situation.
Both CCL21-mCherry and CCL21DC-mCherry supported trans-
migration but Ca chelation reduced the number of transmigration
events only in CCL21DC-mCherry expressing monolayers
(62.4% reduction, Figure 4F;Movie S6), which lack the unphysio-
logical accumulation of CCL21 (see Figure S2A) and thus lack a
prepatterned CCL21 gradient across the monolayer (similarly to
the tissue context, Figure 1E). These results suggest that DCs
induce a transient Ca signal in LECs, which triggers acute
CCL21 secretion and possibly enables opening of the endothelial
junctions, as described for blood endothelia (Huang et al., 1993).
Although the decisive role of chemokines in leukocyte extrav-
asation is well established, it has remained unclear if and how
chemokines act during the actual transmigration process. Our
finding that CCL21 is acutely secreted upon contact between
DCs and LECs extend data by Shulman et al. (2011), which sug-
gested that the chemokine CCL2 is released by blood endothelia
in response to interactions with extravasating lymphocytes.
While we show that a direct DC-LEC contact is sufficient to
trigger chemokine release even in the absence of cytoskeletal
force generation (Figure 4E), we found that applying mechanical
pushing forces on LECs, and thus increasing LEC plasma mem-
brane tension (Apodaca, 2002), can also trigger Ca flux and
CCL21 release in vitro (Figures S2G–S2I). This was in line withthe observation that transmigrating DCs considerably deformed
LECs in dermal tissue (Figures 4A and 4B) and might suggest
thatmolecular andmechanical triggers perpetuate the intravasa-
tion process in concert.
Earlier, long range CCL21 gradients were shown to guide DCs
to the vicinity of lymphatic vessels (Weber et al., 2013). However,
LEC penetration could not be explained by a simple concentra-
tion gradient across the endothelium as intra-luminal CCL21
concentrations are lower than those on the abluminal basement
membrane (Weber et al., 2013; Russo et al., 2016). The acute
chemokine release that we demonstrate exposes the leading
edge of DCs to a burst of very steep CCL21 gradient, which
will likely ‘‘motivate’’ the cell to locally push into the endothelium.
At sites of loose button-like LEC-LEC junctions (Baluk et al.,
2007), physical pushing might open the junction and allow entry
from the confined interstitial environment into the lymphatic
capillary lumen where physical resistance is lower (Figure 4G).
In addition, local chemokine release might boost transmigration
by attracting more transmigrating cells toward the specific entry
portal, or provide local guidance and thereby determine the
actual site of penetration. Taken together, our data show that
the barrier cells take a more active role in their penetration
than previously anticipated.
EXPERIMENTAL PROCEDURES
Mice
Wild-type C57BL/6J (Charles River Laboratories),Ccr7/ (Fo¨rster et al., 1999)
and Itgb2/ (Wilson et al., 1993) male and female mice were bred and main-
tained according to the local rules (Institutional Review Board approval 66018/
3-II/3b/2010). Mice were sacrificed at the age of 6–8 weeks for the ear prepa-
ration and at the age of 8–12 weeks for the bone marrow extraction.
Ear Sheet Preparation and Explant DC Intravasation Assay
Ears of sacrificed mice were prepared as previously described (Weber et al.,
2013). Ear sheets were fixed with 4% paraformaldehyde (PFA) in PBS at
room temperature for 250 or prepared for the DC lymphatic capillary intravasa-
tion assay as follows: the ventral half of the ear wasmounted between a 0.5mL
microcentrifuge tube lid and the body of the tube, of which the lower part was
cut off. The 1.5 cm2 well formed by the cut tube was filled with 200 mL of R10
with or without 50,000 (Figures 1B–1F) or 100,000 (Figures S2E and S2F)
TAMRA-labeled DCs. Unattached DCs were washed off with R10 after 300 in-
cubation at +37C and 5%CO2 and incubated in R10 for additional 1–3 hr (Fig-
ures 1B–1F). As Itgb2/ DCs are slower in invading ear explants, Itgb2/
DCs and wild-type controls were kept on the ear explants for 7 hr (i.e., for
the whole duration of the experiment) (Figures S2E and S2F). The experiments
were terminated by washing the ear once with PBS followed by fixation with
4% PFA in PBS at room temperature for 250.
CCL21 Quantification in Transmission Electron Microscopy
For the quantification of extra-LEC CCL21, we used two independent samples
devoid of DCs (control) and four independent samples with DCs (+DCs). Each
sample contained two to five lymphatic vessels. All extracellular CCL21-immu-
nometal particles within 1 mmdistance to the interstitial (basolateral) side of the
lymphatic vessel endothelial cell were quantified. The particles were classified
based on their location either in the intact area or in the area displaying DC-
associated tissue alterations (i.e., disorganized collagen bundles and/or local
detachment of LECs from the interstitial extracellular matrix). Finally, the par-
ticle number was normalized to the corresponding endothelial length.
Measurements of mCherry Signals of the Culture Supernatant
The bulk secretion of CCL21 was measured by analyzing mCherry intensities
in the culture supernatant. To measure the amounts of CCL21-mCherry,Cell Reports 19, 902–909, May 2, 2017 907
CCL21DN-mCherry, and CCL21DC-mCherry (Figure 2B), culture superna-
tant was collected 48 hr after full confluency of the LEC culture and the
last media change. For the experiments shown in Figure 3, we used
CCL21DC-mCherry because it has low affinity to culture substrate (Fig-
ure S2A), and the changes in secretion should be immediately reflected in
the mCherry intensity in the supernatant. Here, culture supernatant was
collected subsequent to 60 5 mM ionomycin (Molecular Probes), 4 hr after
washout of 1 hr 10 mM BAPTA-AM (Life Technologies, B6769) treatment or
corresponding control (DMSO) treatments. Results were normalized to the
background fluorescence of the MV2 culture media. For the information on
measurement and quantification (Figure 2B), see the Supplemental Experi-
mental Procedures.
Live TIRF Imaging of CCL21-mCherry-Positive Vesicles
Ionomycin (final concentration 5 mM, Molecular Probes) was added to
the CCL21-mCherry expressing LECs and imaging was started 10 s
later whereas latrunculin B (500 ng/mL, Merck Millipore 428020) and
nocodazole (500 nM, Sigma, m1404) were added on the LECs 300 prior
to imaging. Vesicle tracks were analyzed with Imaris (Bitplane). Averages
of all the tracks/cell, which lasted for longer than 2.5 s, are shown in
Figure 3E. The basolateral secretion events were quantified from ac-
quired movies by using FiJi software. Only events in which the vesicles
were observed prior to the ‘‘flash’’ and vesicle-like signal was severely
decreased or totally absent after the flash were quantified as a secretion
event (Figure 3D).
In Vitro DC Transmigration Assay
Activated DCs were centrifuged (300RCF, 50) and resuspended in MV2
(Promocell) culture media. A total of 40,000 DCs (CCL21DC-mCherry
monolayers; Figures 4F and S2D; Movie S4) were added on 1.5 cm2 well
of days 4–5 confluent LECs. Due to more efficient transmigration of
DCs on CCL21-mCherry monolayers in comparison to CCL21DC-mCherry
monolayers, DC number was reduced to 25,000 for Figure 4F CCL21-
mCherry monolayers. The acquired movies were quantified for the num-
ber of DCs beneath the monolayer at 1 hr for CCL21-mCherry or at 3 hr
for CCL21DC-mCherry expressing LEC monolayers (Figure 4F; Movie
S6). For quantification of transmigration efficiency on non-infected or
CCL21-mCherry full-length or mutant construct expressing LEC mono-
layers (Figure S2D), a percentage of transmigrated DC of all DCs was
determined.
LEC Ca Sensor Assays
For the Ca-sensor assays, fresh media, DC-conditioned media, or either
TAMRA-labeled non-treated or Mycalolide B-treated DCs were carefully
added on LEC monolayers treated for 500 with 10 mM Oregon Green
BAPTA-AM. The time-lapse imaging was started after 100. For the cell pop-
ulation analysis (Figure 4E), imaging lasted for 100 and the number of LECs
displaying transient Ca peaks was quantified from acquired videos. All the
Ca sensor experiments were carried out in the absence of serum or added
growth factors. See the Supplemental Experimental Procedures for detailed
protocol.
Statistics
Prism5 and Prism6 software (GraphPad softwares) was used to test the
normality of the data (D’Agostino and Pearson omnibus normality test or
Kolmogorov-Smirnov normality test) and for subsequent parametrical t test
(two-tailed with Welch’s correction) or non-parametrical Mann-Whitney tests.
Figure legends indicate number of independent experiments and biological
replicates (n) used for statistical analysis.
Other Procedures
Generation and labeling of DCs, ear sheet staining, preparation of transmission
electron microscopy samples, construction of lentiviral expression plasmids,
virus production, LEC culture and infections, LEC staining,microscopy setups,
mechanical pushing of the LECs, image analysis, and identification of putative
nuclear localizing signal in CCL21 are outlined in the Supplemental Experi-
mental Procedures.908 Cell Reports 19, 902–909, May 2, 2017SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
two figures, and six movies and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2017.04.027.
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